Revision history of "A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study" (Q42170053)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

16 July 2023

  • curprev 03:0703:07, 16 July 2023 KrBot talk contribs 44,590 bytes −1 Set a claim value: title (P1476): A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study undo
  • curprev 03:0703:07, 16 July 2023 KrBot talk contribs 44,591 bytes −1 Changed Dutch label: A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study undo (restore)
  • curprev 03:0703:07, 16 July 2023 KrBot talk contribs 44,592 bytes −1 Changed English label: A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study undo (restore)

21 January 2022

11 October 2021

28 September 2021

16 September 2021

16 November 2019

25 August 2019

18 July 2019

3 January 2019

15 December 2018

28 November 2018

17 October 2017